Table 1.
Baseline characteristics of study participants (n = 10).a
| Clinical parameter | Total (n = 10) | Males (n = 5) | Females (n = 5) |
|---|---|---|---|
| Age (years) | 49 (44.75–50.75) | 47 (44–50) | 50 (48–51) |
| Gender (male; n, %) | 5/10 (50%) | 5 | 5 |
| Resting heart rate (bpm) | 84.3 ± 10.9 | 86.2 ± 10.1 | 82.4 ± 12.6 |
| Resting systolic blood pressure (mmHg) | 131 ± 9.4 | 137 ± 9.1 | 125 ± 5* |
| Resting diastolic blood pressure (mmHg) | 83 ± 7.1 | 83 ± 4.5 | 83 ± 9.7 |
| Hemoglobin (g/L) | 141.1 ± 16.7 | 154.6 ± 4.8 | 124.3 ± 5.3 |
| Serum calcium (mmol/L) | 2.38 ± 0.05 | 2.38 ± 0.04 | 2.38 ± 0.06 |
| sPi (mmol/L) | 0.98 ± 0.12 | 0.92 ± 0.12 | 1.03 ± 0.11 |
| Serum creatinine (mmol/L) | 71.5 ± 11.1 | 79.0 ± 8.6 | 64.0 ± 8.0 |
| eGFR (mL/min/1.73 m2) | 98.9 ±12.1 | 99.4 ± 11.0 | 98.3 ± 14.4 |
| Serum sKl (pg/mL) | 483 (423–767) | 423 (415–614) | 669 (448–1095) |
| Blood glucose reading (optima glucometer; mmol/L) | 5.07 ± 0.42 | 5.36 ± 0.15 | 4.78 ± 0.41 |
eGFR: estimated glomerular filtration rate; sPi: serum phosphate; sKl: soluble klotho.
a T-test or Mann–Whitney U-test performed for continuous variables between gender groups.
*p < 0.05 compared to males.